{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T06:57:51Z","timestamp":1794207471339,"version":"4.8.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Wuhan Municipal Health Commission","award":["EG20A02"],"award-info":[{"award-number":["EG20A02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["glob health res policy"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>With the continuation of the COVID-19 pandemic, some COVID-19 patients have become reinfected with the virus. Viral gene sequencing has found that some of these patients were reinfected by the different and others by same strains. This has raised concerns about the effectiveness of immunity after infection and the reliability of vaccines. To this end, we conducted a systematic review to assess the characteristics of patients with reinfection and possible causes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A systematic search was conducted across eight databases: PubMed, Embase, Web of Science, The Cochrane Library, CNKI, WanFang, VIP and SinoMed from December 1, 2019 to September 1, 2021\n                      <jats:bold>.<\/jats:bold>\n                      The quality of included studies were assessed using JBI critical appraisal tools and Newcastle\u2013Ottawa Scale.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study included 50 studies from 20 countries. There were 118 cases of reinfection. Twenty-five patients were reported to have at least one complication. The shortest duration between the first infection and reinfection was 19\u00a0days and the longest was 293\u00a0days. During the first infection and reinfection, cough (51.6% and 43.9%) and fever (50% and 30.3%) were the most common symptoms respectively. Nine patients recovered, seven patients died, and five patients were hospitalized, but 97 patients\u2019 prognosis were unknown. B.1 is the most common variant strain at the first infection. B.1.1.7, B.1.128 and B.1.351 were the most common variant strains at reinfection. Thirty-three patients were infected by different strains and 9 patients were reported as being infected with the same strain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our research shows that it is possible for rehabilitated patients to be reinfected by SARS-COV-2. To date, the causes and risk factors of COVID-19 reinfection are not fully understood. For patients with reinfection, the diagnosis and management should be consistent with the treatment of the first infection. The public, including rehabilitated patients, should be fully vaccinated, wear masks in public places, and pay attention to maintaining social distance to avoid reinfection with the virus.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41256-022-00245-3","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:04:22Z","timestamp":1651194262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Reinfection in patients with COVID-19: a systematic review"],"prefix":"10.1016","volume":"7","author":[{"given":"Xiangying","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghui","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"245_CR1","unstructured":"WHO. WHO Coronavirus Disease (COVID-19) Situation Dashboard. https:\/\/covid19.who.int\/. Accessed 21 Nov 2021."},{"issue":"11","key":"245_CR2","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41564-020-0771-4","volume":"5","author":"MF Boni","year":"2020","unstructured":"Boni MF, Lemey P, Jiang X, et al. Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. Nat Microbiol. 2020;5(11):1408\u201317.","journal-title":"Nat Microbiol"},{"key":"245_CR3","doi-asserted-by":"publisher","first-page":"587269","DOI":"10.3389\/fcimb.2020.587269","volume":"10","author":"MY Wang","year":"2020","unstructured":"Wang MY, Zhao R, Gao LJ, Gao XF, Wang DP, Cao JM. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front Cell Infect Microbiol. 2020;10:587269.","journal-title":"Front Cell Infect Microbiol."},{"key":"245_CR4","doi-asserted-by":"publisher","first-page":"e9725","DOI":"10.7717\/peerj.9725","volume":"8","author":"T Hu","year":"2020","unstructured":"Hu T, Liu Y, Zhao M, Zhuang Q, Xu L, He Q. A comparison of COVID-19, SARS and MERS. PeerJ. 2020;8:e9725.","journal-title":"PeerJ."},{"issue":"1","key":"245_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1080\/22221751.2021.1902753","volume":"10","author":"NN Gaudreault","year":"2021","unstructured":"Gaudreault NN, Carossino M, Morozov I, et al. Experimental re-infected cats do not transmit SARS-CoV-2. Emerg Microbes Infect. 2021;10(1):638\u201350.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"245_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1080\/22221751.2021.1913974","volume":"10","author":"M Brustolin","year":"2021","unstructured":"Brustolin M, Rodon J, Rodriguez de la Concepcion ML, et al. Protection against reinfection with D614-or G614-SARS-CoV-2 isolates in golden Syrian hamster. Emerg Microbes Infect. 2021;10(1):797\u2013809.","journal-title":"Emerg Microbes Infect"},{"issue":"6505","key":"245_CR7","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.abc5343","volume":"369","author":"W Deng","year":"2020","unstructured":"Deng W, Bao L, Liu J, et al. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020;369(6505):818.","journal-title":"Science."},{"key":"245_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1275","author":"KK To","year":"2020","unstructured":"To KK, Hung IF, Ip JD, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1275.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"245_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S1473-3099(20)30764-7","volume":"21","author":"RL Tillett","year":"2021","unstructured":"Tillett RL, Sevinsky JR, Hartley PD, et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2021;21(1):52\u20138.","journal-title":"Lancet Infect Dis"},{"key":"245_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27200","author":"C Borgogna","year":"2021","unstructured":"Borgogna C, De Andrea M, Griffante G, et al. SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response. J Med Virol. 2021. https:\/\/doi.org\/10.1002\/jmv.27200.","journal-title":"J Med Virol"},{"issue":"1","key":"245_CR11","doi-asserted-by":"publisher","first-page":"6625","DOI":"10.1038\/s41598-021-85363-7","volume":"11","author":"A Urhan","year":"2021","unstructured":"Urhan A, Abeel T. Emergence of novel SARS-CoV-2 variants in the Netherlands. Sci Rep. 2021;11(1):6625.","journal-title":"Sci Rep"},{"issue":"23","key":"245_CR12","doi-asserted-by":"publisher","first-page":"846","DOI":"10.15585\/mmwr.mm7023a3","volume":"70","author":"P Paul","year":"2021","unstructured":"Paul P, France AM, Aoki Y, et al. Genomic surveillance for SARS-CoV-2 variants circulating in the United States, December 2020-May 2021. MMWR Morb Mortal Wkly Rep. 2021;70(23):846\u201350.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"245_CR13","doi-asserted-by":"publisher","first-page":"109415","DOI":"10.1016\/j.celrep.2021.109415","volume":"36","author":"M Hoffmann","year":"2021","unstructured":"Hoffmann M, Hofmann-Winkler H, Kr\u00fcger N, et al. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell Rep. 2021;36(3):109415.","journal-title":"Cell Rep."},{"key":"245_CR14","unstructured":"WHO. Tracking SARS-CoV-2 variants. WHO. https:\/\/www.who.int\/zh\/activities\/tracking-SARS-CoV-2-variants. Accessed 7 Sept 2021."},{"issue":"6538","key":"245_CR15","doi-asserted-by":"publisher","first-page":"eabg3055","DOI":"10.1126\/science.abg3055","volume":"372","author":"NG Davies","year":"2021","unstructured":"Davies NG, Abbott S, Barnard RC, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372(6538):eabg3055.","journal-title":"Science"},{"issue":"5","key":"245_CR16","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/S2468-2667(21)00055-4","volume":"6","author":"MS Graham","year":"2021","unstructured":"Graham MS, Sudre CH, May A, et al. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. Lancet Public Health. 2021;6(5):e335\u201345.","journal-title":"Lancet Public Health."},{"key":"245_CR17","doi-asserted-by":"crossref","unstructured":"Pulliam JRC, van Schalkwyk C, Govender N, et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. medRxiv. 2021:2021.2011.2011.21266068.","DOI":"10.1101\/2021.11.11.21266068"},{"key":"245_CR18","unstructured":"Yinghui Jin XR, Jie Zhou, Jing Guo, Chunmei Hao, Mengxue Zheng, Rong Zhang, Qiao Huang, Ruiling Li, Xiaomei Yao. Patients showing reinfection with COVID-19: a systematic review and meta-analysis protocol. PROSPERO. 2021. CRD42021265333. https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42021265333. Accessed 15 Mar 2022."},{"key":"245_CR19","unstructured":"PRISMA 2020 statement. https:\/\/www.bmj.com\/content\/372\/bmj.n71. Accessed 9 Mar 2022."},{"key":"245_CR20","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/rmv.2260","volume":"32","author":"EO Murchu","year":"2021","unstructured":"Murchu EO, Byrne P, Carty PG, et al. Quantifying the risk of SARS-CoV-2 reinfection over time. Rev Med Virol. 2021;32:2260.","journal-title":"Rev Med Virol."},{"issue":"Suppl 2","key":"245_CR21","doi-asserted-by":"publisher","first-page":"S257","DOI":"10.1016\/j.mjafi.2021.02.010","volume":"77","author":"LM Pinto","year":"2021","unstructured":"Pinto LM, Nanda V, Sunavala A, Rodriques C. Reinfection in COVID-19: a scoping review. Med J Armed Forces India. 2021;77(Suppl 2):S257-s263.","journal-title":"Med J Armed Forces India"},{"issue":"5","key":"245_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5501\/wjv.v9.i5.79","volume":"9","author":"S SeyedAlinaghi","year":"2020","unstructured":"SeyedAlinaghi S, Oliaei S, Kianzad S, et al. Reinfection risk of novel coronavirus (COVID-19): a systematic review of current evidence. World J Virol. 2020;9(5):79\u201390.","journal-title":"World J Virol"},{"issue":"7","key":"245_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/23744235.2021.1905174","volume":"53","author":"AT Roberts","year":"2021","unstructured":"Roberts AT, Piani F, Longo B, Andreini R, Meini S. Reinfection of SARS-CoV-2\u2014analysis of 23 cases from the literature. Infect Dis (Lond). 2021;53(7):479\u201385.","journal-title":"Infect Dis (Lond)"},{"issue":"6","key":"245_CR24","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1136\/jim-2021-001853","volume":"69","author":"J Wang","year":"2021","unstructured":"Wang J, Kaperak C, Sato T, Sakuraba A. COVID-19 reinfection: a rapid systematic review of case reports and case series. J Investig Med. 2021;69(6):1253\u20135.","journal-title":"J Investig Med"},{"key":"245_CR25","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.21-0365","author":"J Massachi","year":"2021","unstructured":"Massachi J, Donohue KC, Kelly JD. Severe acute respiratory syndrome coronavirus 2 reinfection cases corroborated by sequencing. Am J Trop Med Hyg. 2021. https:\/\/doi.org\/10.4269\/ajtmh.21-0365.","journal-title":"Am J Trop Med Hyg"},{"key":"245_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab380","author":"MC Choudhary","year":"2021","unstructured":"Choudhary MC, Crain CR, Qiu X, Hanage W, Li JZ. SARS-CoV-2 sequence characteristics of COVID-19 persistence and reinfection. Clin Infect Dis. 2021. https:\/\/doi.org\/10.1093\/cid\/ciab380.","journal-title":"Clin Infect Dis"},{"key":"245_CR27","doi-asserted-by":"publisher","first-page":"103130","DOI":"10.1016\/j.amsu.2021.103130","volume":"72","author":"RA Dhillon","year":"2021","unstructured":"Dhillon RA, Qamar MA, Gilani JA, et al. The mystery of COVID-19 reinfections: a global systematic review and meta-analysis. Ann Med Surg (Lond). 2021;72:103130.","journal-title":"Ann Med Surg (Lond)."},{"key":"245_CR28","unstructured":"Institute JB. JBI critical appraisal tools. https:\/\/jbi.global\/. Accessed 23 Sept 2021."},{"issue":"1","key":"245_CR29","first-page":"7","volume":"7","author":"LL Ma","year":"2020","unstructured":"Ma LL, Wang YY, Yang ZH, Huang D, Weng H, Zeng XT. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020;7(1):7.","journal-title":"Mil Med Res"},{"key":"245_CR30","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 23 Sept 2021."},{"key":"245_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1451","author":"V Gupta","year":"2020","unstructured":"Gupta V, Bhoyar RC, Jain A, et al. Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1451.","journal-title":"Clin Infect Dis"},{"key":"245_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1436","author":"D Larson","year":"2020","unstructured":"Larson D, Brodniak SL, Voegtly LJ, et al. A case of early re-infection with SARS-CoV-2. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1436.","journal-title":"Clin Infect Dis"},{"issue":"18","key":"245_CR33","doi-asserted-by":"publisher","first-page":"2100423","DOI":"10.2807\/1560-7917.ES.2021.26.18.2100423","volume":"26","author":"T Staub","year":"2021","unstructured":"Staub T, Arendt V, Lasso de la Vega EC, et al. Case series of four re-infections with a SARS-CoV-2 B1351 variant, Luxembourg, February 2021. Euro Surveill. 2021;26(18):2100423.","journal-title":"Euro Surveill."},{"issue":"8","key":"245_CR34","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s10096-021-04221-6","volume":"40","author":"M Salehi-Vaziri","year":"2021","unstructured":"Salehi-Vaziri M, Jalali T, Farahmand B, et al. Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran. Eur J Clin Microbiol Infect Dis. 2021;40(8):1713\u20139.","journal-title":"Eur J Clin Microbiol Infect Dis."},{"issue":"3","key":"245_CR35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/infdis\/jiab553","volume":"225","author":"J Klein","year":"2022","unstructured":"Klein J, Brito AF, Trubin P, et al. Longitudinal immune profiling of a severe acute respiratory syndrome coronavirus 2 reinfection in a solid organ transplant recipient. J Infect Dis. 2022;225(3):374\u201384.","journal-title":"J Infect Dis"},{"key":"245_CR36","doi-asserted-by":"publisher","first-page":"631769","DOI":"10.3389\/fmed.2021.631769","volume":"8","author":"J Shastri","year":"2021","unstructured":"Shastri J, Parikh S, Agrawal S, et al. Clinical, serological, whole genome sequence analyses to confirm SARS-CoV-2 reinfection in patients from Mumbai, India. Front Med (Lausanne). 2021;8:631769.","journal-title":"Front Med (Lausanne)."},{"issue":"5","key":"245_CR37","doi-asserted-by":"publisher","first-page":"791.e791","DOI":"10.1016\/j.cmi.2021.02.010","volume":"27","author":"P Vetter","year":"2021","unstructured":"Vetter P, Cordey S, Schibler M, et al. Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection. Clin Microbiol Infect. 2021;27(5):791.e791-794.","journal-title":"Clin Microbiol Infect"},{"key":"245_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab014","author":"D Harrington","year":"2021","unstructured":"Harrington D, Kele B, Pereira S, et al. Confirmed reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant VOC-202012\/01. Clin Infect Dis. 2021. https:\/\/doi.org\/10.1093\/cid\/ciab014.","journal-title":"Clin Infect Dis"},{"key":"245_CR39","doi-asserted-by":"publisher","unstructured":"Prado-Vivar B, Becerra-Wong M, Guadalupe JJ, et al. COVID-19 re-infection by a phylogenetically distinct SARS-CoV-2 variant, first confirmed event in South America. In: SSRN; 2020. https:\/\/doi.org\/10.2139\/ssrn.3686174.","DOI":"10.2139\/ssrn.3686174"},{"key":"245_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000003924","author":"MO Moschetta","year":"2021","unstructured":"Moschetta MO, Hadi RA, Franco RF, et al. COVID-19 Reinfection by the gamma variant in kidney transplant recipients. Transplantation. 2021. https:\/\/doi.org\/10.1097\/tp.0000000000003924.","journal-title":"Transplantation"},{"issue":"7","key":"245_CR41","doi-asserted-by":"publisher","first-page":"e244507","DOI":"10.1136\/bcr-2021-244507","volume":"14","author":"G Scarpati","year":"2021","unstructured":"Scarpati G, Piazza O, Pagliano P, Rizzo F. COVID-19: a confirmed case of reinfection in a nurse. BMJ Case Rep. 2021;14(7):e244507.","journal-title":"BMJ Case Rep."},{"issue":"7","key":"245_CR42","doi-asserted-by":"publisher","first-page":"ofab329","DOI":"10.1093\/ofid\/ofab329","volume":"8","author":"M Massanella","year":"2021","unstructured":"Massanella M, Martin-Urda A, Mateu L, et al. Critical presentation of a severe acute respiratory syndrome coronavirus 2 reinfection: a case report. Open Forum Infect Dis. 2021;8(7):ofab329.","journal-title":"Open Forum Infect Dis."},{"issue":"6","key":"245_CR43","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.jinf.2021.03.004","volume":"82","author":"MI Garvey","year":"2021","unstructured":"Garvey MI, Casey AL, Wilkinson MAC, et al. Details of SARS-CoV-2 reinfections at a major UK tertiary centre. J Infect. 2021;82(6):e29\u201330.","journal-title":"J Infect"},{"key":"245_CR44","doi-asserted-by":"publisher","first-page":"104772","DOI":"10.1016\/j.meegid.2021.104772","volume":"90","author":"JD Siqueira","year":"2021","unstructured":"Siqueira JD, Goes LR, Alves BM, et al. Distinguishing SARS-CoV-2 bonafide re-infection from pre-existing minor variant reactivation. Infect Genet Evol. 2021;90:104772.","journal-title":"Infect Genet Evol."},{"key":"245_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ijid.2021.04.073","volume":"108","author":"G Sevillano","year":"2021","unstructured":"Sevillano G, Ortega-Paredes D, Loaiza K, Zurita-Salinas C, Zurita J. Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: a case study. Int J Infect Dis. 2021;108:53\u20136.","journal-title":"Int J Infect Dis"},{"key":"245_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab136","author":"O Kulkarni","year":"2021","unstructured":"Kulkarni O, Narreddy S, Zaveri L, Kalal IG, Tallapaka KB, Sowpati DT. Evidence of SARS-CoV-2 reinfection without mutations in Spike protein. Clin Infect Dis. 2021. https:\/\/doi.org\/10.1093\/cid\/ciab136.","journal-title":"Clin Infect Dis"},{"key":"245_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1421","author":"JS Lee","year":"2020","unstructured":"Lee JS, Kim SY, Kim TS, et al. Evidence of severe acute respiratory syndrome coronavirus 2 reinfection after recovery from mild coronavirus disease 2019. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1421.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"245_CR48","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3201\/eid2705.204912","volume":"27","author":"N Fintelman-Rodrigues","year":"2021","unstructured":"Fintelman-Rodrigues N, da Silva APD, Dos Santos MC, et al. Genetic evidence and host immune response in persons reinfected with SARS-CoV-2, Brazil. Emerg Infect Dis. 2021;27(5):1446\u201353.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"245_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jinf.2021.05.014","volume":"83","author":"V Fonseca","year":"2021","unstructured":"Fonseca V, de Jesus R, Adelino T, et al. Genomic evidence of SARS-CoV-2 reinfection case with the emerging B.1.2 variant in Brazil. J Infect. 2021;83(2):237\u201379.","journal-title":"J Infect."},{"issue":"5","key":"245_CR50","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3201\/eid2705.210191","volume":"27","author":"CKV Nonaka","year":"2021","unstructured":"Nonaka CKV, Franco MM, Gr\u00e4f T, et al. Genomic evidence of SARS-CoV-2 reinfection involving E484K spike mutation, Brazil. Emerg Infect Dis. 2021;27(5):1522\u20134.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"245_CR51","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/vaccines9030282","volume":"9","author":"JD Ram\u00edrez","year":"2021","unstructured":"Ram\u00edrez JD, Mu\u00f1oz M, Ballesteros N, et al. Phylogenomic evidence of reinfection and persistence of SARS-CoV-2: first report from Colombia. Vaccines (Basel). 2021;9(3):282.","journal-title":"Vaccines (Basel)."},{"key":"245_CR52","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ijid.2021.07.036","volume":"110","author":"AN Alshukairi","year":"2021","unstructured":"Alshukairi AN, El-Kafrawy SA, Dada A, et al. Re-infection with a different SARS-CoV-2 clade and prolonged viral shedding in a hematopoietic stem cell transplantation patient. Int J Infect Dis. 2021;110:267\u201371.","journal-title":"Int J Infect Dis"},{"key":"245_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2021.04.009","author":"AL Aguilar-Shea","year":"2021","unstructured":"Aguilar-Shea AL, Guti\u00e9rrez-Mart\u00edn-Arroyo J, Vacas-C\u00f3rdoba M, Gallardo-Mayo C. Reinfection by SARS-CoV-2: the first one in a family reported in Spain. Med Clin (Barc). 2021. https:\/\/doi.org\/10.1016\/j.medcli.2021.04.009.","journal-title":"Med Clin (Barc)"},{"key":"245_CR54","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1538","author":"M Mulder","year":"2020","unstructured":"Mulder M, Vegt D, Oude Munnink B, et al. Reinfection of severe acute respiratory syndrome coronavirus 2 in an immunocompromised patient: a case report. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1538.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"245_CR55","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1002\/jmv.26948","volume":"93","author":"MS Dhar","year":"2021","unstructured":"Dhar MS, Asokachandran V, Uppili B, et al. Reinfection or reactivation: genome-based two distinct SNP profile of SARS-CoV2 repositivity in an Indian case. J Med Virol. 2021;93(7):4152\u20135.","journal-title":"J Med Virol"},{"key":"245_CR56","doi-asserted-by":"publisher","unstructured":"Goldman JD, Wang K, Roltgen K, et al. Reinfection with SARS-CoV-2 and failure of humoral immunity: a case report. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.09.22.20192443.","DOI":"10.1101\/2020.09.22.20192443"},{"key":"245_CR57","doi-asserted-by":"publisher","unstructured":"Marquez L, Koy T, Spinler JK, et al. Reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 variant in an immunocompromised adolescent. Infect Control Hosp Epidemiol. 2021:1\u20132. https:\/\/doi.org\/10.1017\/ice.2021.195","DOI":"10.1017\/ice.2021.195"},{"key":"245_CR58","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000003280","author":"EP Buddingh","year":"2021","unstructured":"Buddingh EP, Vossen A, Lamb HJ, van der Palen RLF, Brinkman DMC. Reinfection with severe acute respiratory syndrome coronavirus 2 without recurrence of multisystem inflammatory syndrome in children. Pediatr Infect Dis J. 2021. https:\/\/doi.org\/10.1097\/inf.0000000000003280.","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"245_CR59","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.1002\/jmv.27154","volume":"93","author":"CY Tang","year":"2021","unstructured":"Tang CY, Wang Y, McElroy JA, et al. Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days. J Med Virol. 2021;93(10):5700\u20133.","journal-title":"J Med Virol"},{"issue":"6","key":"245_CR60","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3201\/eid2706.210558","volume":"27","author":"MR Amorim","year":"2021","unstructured":"Amorim MR, Souza WM, Barros ACG Jr, et al. Respiratory viral shedding in healthcare workers reinfected with SARS-CoV-2, Brazil, 2020. Emerg Infect Dis. 2021;27(6):1737\u201340.","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"245_CR61","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1002\/jmv.27066","volume":"93","author":"F Novazzi","year":"2021","unstructured":"Novazzi F, Baj A, Genoni A, et al. SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients. J Med Virol. 2021;93(9):5648\u20139.","journal-title":"J Med Virol."},{"key":"245_CR62","doi-asserted-by":"publisher","first-page":"198421","DOI":"10.1016\/j.virusres.2021.198421","volume":"299","author":"M Salehi-Vaziri","year":"2021","unstructured":"Salehi-Vaziri M, Omrani MD, Pouriayevali MH, et al. SARS-CoV-2 presented moderately during two episodes of the infection with lack of antibody responses. Virus Res. 2021;299:198421.","journal-title":"Virus Res."},{"key":"245_CR63","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1590\/s1678-9946202163036","volume":"63","author":"CM Romano","year":"2021","unstructured":"Romano CM, Felix AC, Paula AV, et al. SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil. Rev Inst Med Trop Sao Paulo. 2021;63:e36.","journal-title":"Rev Inst Med Trop Sao Paulo."},{"issue":"4","key":"245_CR64","doi-asserted-by":"publisher","first-page":"115516","DOI":"10.1016\/j.diagmicrobio.2021.115516","volume":"101","author":"CH Camargo","year":"2021","unstructured":"Camargo CH, Gon\u00e7alves CR, Pagnoca E, et al. SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil. Diagn Microbiol Infect Dis. 2021;101(4):115516.","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"4","key":"245_CR65","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/v13040661","volume":"13","author":"TT Brehm","year":"2021","unstructured":"Brehm TT, Pfefferle S, von Possel R, et al. SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies. Viruses. 2021;13(4):661.","journal-title":"Viruses."},{"issue":"8","key":"245_CR66","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.7326\/L21-0108","volume":"174","author":"CH Tomkins-Tinch","year":"2021","unstructured":"Tomkins-Tinch CH, Daly JS, Gladden-Young A, et al. SARS-CoV-2 reinfection in a liver transplant recipient. Ann Intern Med. 2021;174(8):1178\u201380.","journal-title":"Ann Intern Med"},{"key":"245_CR67","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ijid.2021.06.004","volume":"108","author":"Y D\u00edaz","year":"2021","unstructured":"D\u00edaz Y, Ortiz A, Weeden A, et al. SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama. Int J Infect Dis. 2021;108:588\u201391.","journal-title":"Int J Infect Dis"},{"key":"245_CR68","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1590\/s1678-9946202163050","volume":"63","author":"ALF Yu","year":"2021","unstructured":"Yu ALF, Liphaus BL, Ferreira PM, et al. SARS-CoV-2 reinfection: report of two cases in Southeast Brazil. Rev Inst Med Trop Sao Paulo. 2021;63:e50.","journal-title":"Rev Inst Med Trop Sao Paulo."},{"key":"245_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab129","author":"N Zucman","year":"2021","unstructured":"Zucman N, Uhel F, Descamps D, Roux D, Ricard JD. Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report. Clin Infect Dis. 2021. https:\/\/doi.org\/10.1093\/cid\/ciab129.","journal-title":"Clin Infect Dis."},{"issue":"7","key":"245_CR70","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1002\/jmv.26997","volume":"93","author":"PR Rani","year":"2021","unstructured":"Rani PR, Imran M, Lakshmi JV, et al. Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape. J Med Virol. 2021;93(7):4163\u20135.","journal-title":"J Med Virol"},{"issue":"5","key":"245_CR71","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3390\/v13050899","volume":"13","author":"D Loconsole","year":"2021","unstructured":"Loconsole D, Sallustio A, Accogli M, et al. Symptomatic SARS-CoV-2 reinfection in a healthy healthcare worker in Italy confirmed by whole-genome sequencing. Viruses-Basel. 2021;13(5):899.","journal-title":"Viruses-Basel."},{"key":"245_CR72","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1850","author":"P Selhorst","year":"2020","unstructured":"Selhorst P, Van Ierssel S, Michiels J, et al. Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1850.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"245_CR73","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/cid\/ciaa1330","volume":"73","author":"J Van Elslande","year":"2021","unstructured":"Van Elslande J, Vermeersch P, Vandervoort K, et al. Symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection by a phylogenetically distinct strain. Clin Infect Dis. 2021;73(2):354\u20136.","journal-title":"Clin Infect Dis"},{"key":"245_CR74","doi-asserted-by":"crossref","unstructured":"Jeffery-Smith A, Iyanger N, Williams SV, et al. Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020. Euro Surveill. 2021;26(5):2100092.","DOI":"10.2807\/1560-7917.ES.2021.26.5.2100092"},{"issue":"5","key":"245_CR75","doi-asserted-by":"publisher","first-page":"e13537","DOI":"10.1111\/eci.13537","volume":"51","author":"P Brouqui","year":"2021","unstructured":"Brouqui P, Colson P, Melenotte C, et al. COVID-19 re-infection. Eur J Clin Investig. 2021;51(5):e13537.","journal-title":"Eur J Clin Investig."},{"key":"245_CR76","doi-asserted-by":"publisher","first-page":"100861","DOI":"10.1016\/j.eclinm.2021.100861","volume":"35","author":"LJ Abu-Raddad","year":"2021","unstructured":"Abu-Raddad LJ, Chemaitelly H, Coyle P, et al. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy. EClinicalMedicine. 2021;35:100861.","journal-title":"EClinicalMedicine."},{"issue":"3","key":"245_CR77","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jinf.2021.01.020","volume":"82","author":"L Adrielle Dos Santos","year":"2021","unstructured":"Adrielle Dos Santos L, Filho PGG, Silva AMF, et al. Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers. J Infect. 2021;82(3):399\u2013406.","journal-title":"J Infect."},{"key":"245_CR78","doi-asserted-by":"publisher","first-page":"100839","DOI":"10.1016\/j.eclinm.2021.100839","volume":"34","author":"X Ren","year":"2021","unstructured":"Ren X, Ren X, Lou J, et al. A systematic review and meta-analysis of discharged COVID-19 patients retesting positive for RT-PCR. EClinicalMedicine. 2021;34:100839.","journal-title":"EClinicalMedicine."},{"issue":"4","key":"245_CR79","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jinf.2021.01.005","volume":"82","author":"AS Breathnach","year":"2021","unstructured":"Breathnach AS, Riley PA, Cotter MP, Houston AC, Habibi MS, Planche TD. Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months. J Infect. 2021;82(4):e11\u20132.","journal-title":"J Infect"},{"key":"245_CR80","doi-asserted-by":"publisher","first-page":"m4961","DOI":"10.1136\/bmj.m4961","volume":"371","author":"S Griffin","year":"2020","unstructured":"Griffin S. Covid-19: antibodies protect against reinfection for at least six months, study finds. BMJ. 2020;371:m4961.","journal-title":"BMJ."},{"issue":"27","key":"245_CR81","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1056\/NEJMcibr2032888","volume":"383","author":"RS Baric","year":"2020","unstructured":"Baric RS. Emergence of a highly fit SARS-CoV-2 variant. N Engl J Med. 2020;383(27):2684\u20136.","journal-title":"N Engl J Med"},{"issue":"7","key":"245_CR82","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.str.2021.05.014","volume":"29","author":"G Cerutti","year":"2021","unstructured":"Cerutti G, Rapp M, Guo Y, et al. Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies. Structure. 2021;29(7):655-663.e654.","journal-title":"Structure."},{"issue":"6544","key":"245_CR83","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1126\/science.abh2644","volume":"372","author":"NR Faria","year":"2021","unstructured":"Faria NR, Mellan TA, Whittaker C, et al. Genomics and epidemiology of the P1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021;372(6544):815\u201321.","journal-title":"Science."},{"issue":"7","key":"245_CR84","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1016\/S2666-5247(21)00068-9","volume":"2","author":"S Jangra","year":"2021","unstructured":"Jangra S, Ye C, Rathnasinghe R, et al. SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe. 2021;2(7):e283\u20134.","journal-title":"Lancet Microbe"},{"key":"245_CR85","doi-asserted-by":"publisher","DOI":"10.1111\/all.15065","author":"G Augusto","year":"2021","unstructured":"Augusto G, Mohsen MO, Zinkhan S, Liu X, Vogel M, Bachmann MF. In vitro data suggest that Indian variant B.1.617 of SARS-CoV-2 escapes neutralization by both receptor affinity and immune evasion. Allergy. 2021. https:\/\/doi.org\/10.1111\/all.15065.","journal-title":"Allergy."},{"key":"245_CR86","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.omtn.2021.07.011","volume":"26","author":"C Chakraborty","year":"2021","unstructured":"Chakraborty C, Saha A, Sharma AR, Bhattacharya M, Lee SS, Agoramoorthy G. D614G mutation eventuates in all VOI and VOC in SARS-CoV-2: Is it part of the positive selection pioneered by Darwin? Mol Ther Nucleic Acids. 2021;26:237\u201341.","journal-title":"Mol Ther Nucleic Acids"},{"key":"245_CR87","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c00857","author":"A Triveri","year":"2021","unstructured":"Triveri A, Serapian SA, Marchetti F, et al. SARS-CoV-2 spike protein mutations and escape from antibodies: a computational model of epitope loss in variants of concern. J Chem Inf Model. 2021. https:\/\/doi.org\/10.1021\/acs.jcim.1c00857.","journal-title":"J Chem Inf Model"},{"key":"245_CR88","doi-asserted-by":"publisher","first-page":"693775","DOI":"10.3389\/fimmu.2021.693775","volume":"12","author":"C Ding","year":"2021","unstructured":"Ding C, He J, Zhang X, et al. Crucial mutations of spike protein on SARS-CoV-2 evolved to variant strains escaping neutralization of convalescent plasmas and RBD-specific monoclonal antibodies. Front Immunol. 2021;12:693775.","journal-title":"Front Immunol."},{"issue":"7841","key":"245_CR89","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/d41586-021-00031-0","volume":"589","author":"E Callaway","year":"2021","unstructured":"Callaway E. Could new COVID variants undermine vaccines? Labs scramble to find out. Nature. 2021;589(7841):177\u20138.","journal-title":"Nature"},{"issue":"7843","key":"245_CR90","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/d41586-021-00121-z","volume":"589","author":"E Callaway","year":"2021","unstructured":"Callaway E. Fast-spreading COVID variant can elude immune responses. Nature. 2021;589(7843):500\u20131.","journal-title":"Nature"},{"issue":"6534","key":"245_CR91","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.abg6105","volume":"371","author":"A Muik","year":"2021","unstructured":"Muik A, Wallisch AK, S\u00e4nger B, et al. Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera. Science. 2021;371(6534):1152\u20133.","journal-title":"Science."},{"key":"245_CR92","doi-asserted-by":"publisher","first-page":"103561","DOI":"10.1016\/j.ebiom.2021.103561","volume":"71","author":"F Gallais","year":"2021","unstructured":"Gallais F, Gantner P, Bruel T, et al. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine. 2021;71:103561.","journal-title":"EBioMedicine."},{"issue":"7","key":"245_CR93","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMc2107799","volume":"385","author":"VV Edara","year":"2021","unstructured":"Edara VV, Pinsky BA, Suthar MS, et al. Infection and vaccine-induced neutralizing-antibody responses to the SARS-CoV-2 B.1.617 variants. N Engl J Med. 2021;385(7):664\u20136.","journal-title":"N Engl J Med."},{"issue":"6","key":"245_CR94","doi-asserted-by":"publisher","first-page":"e170721187995","DOI":"10.2174\/1871526520666201116095934","volume":"21","author":"E Mehraeen","year":"2021","unstructured":"Mehraeen E, Salehi MA, Behnezhad F, Moghaddam HR, SeyedAlinaghi S. Transmission modes of COVID-19: a systematic review. Infect Disord Drug Targets. 2021;21(6):e170721187995.","journal-title":"Infect Disord Drug Targets."},{"issue":"1","key":"245_CR95","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40001-021-00539-1","volume":"26","author":"O Dadras","year":"2021","unstructured":"Dadras O, Alinaghi SAS, Karimi A, et al. Effects of COVID-19 prevention procedures on other common infections: a systematic review. Eur J Med Res. 2021;26(1):67.","journal-title":"Eur J Med Res"},{"issue":"1","key":"245_CR96","first-page":"e14","volume":"9","author":"S SeyedAlinaghi","year":"2021","unstructured":"SeyedAlinaghi S, Afsahi AM, MohsseniPour M, et al. Late complications of COVID-19; a systematic review of current evidence. Arch Acad Emerg Med. 2021;9(1):e14.","journal-title":"Arch Acad Emerg Med."},{"issue":"1","key":"245_CR97","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.5001\/omj.2022.52","volume":"37","author":"I Al-Jahdhami","year":"2022","unstructured":"Al-Jahdhami I, Al-Mawali A, Bennji SM. Respiratory complications after COVID-19. Oman Med J. 2022;37(1):e343.","journal-title":"Oman Med J."},{"key":"245_CR98","doi-asserted-by":"publisher","first-page":"757605","DOI":"10.3389\/fmed.2021.757605","volume":"8","author":"J Wang","year":"2021","unstructured":"Wang J, Zhu K, Xue Y, Wen G, Tao L. Research progress in the treatment of complications and sequelae of COVID-19. Front Med (Lausanne). 2021;8:757605.","journal-title":"Front Med (Lausanne)."},{"key":"245_CR99","unstructured":"European Centre for Disease Prevention and Control (2020) Reinfection with SARS-CoV-2: Considerations for Public Health Response. European Centre for Disease Prevention and Control. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/threat-assessment-brief-reinfection-sars-cov-2. Accessed 22 Oct 2021."},{"key":"245_CR100","unstructured":"Investigative Criteria for Suspected Cases of SARS-CoV-2 Reinfection (ICR) Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/php\/invest-criteria.html. Accessed 22 Oct 2021."},{"issue":"10233","key":"245_CR101","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0140-6736(20)30868-0","volume":"395","author":"B Atkinson","year":"2020","unstructured":"Atkinson B, Petersen E. SARS-CoV-2 shedding and infectivity. Lancet. 2020;395(10233):1339\u201340.","journal-title":"Lancet"}],"container-title":["Global Health Research and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41256-022-00245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41256-022-00245-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41256-022-00245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:26:51Z","timestamp":1768404411000},"score":1,"resource":{"primary":{"URL":"https:\/\/ghrp.biomedcentral.com\/articles\/10.1186\/s41256-022-00245-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["245"],"URL":"https:\/\/doi.org\/10.1186\/s41256-022-00245-3","relation":{},"ISSN":["2397-0642"],"issn-type":[{"value":"2397-0642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"19 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YH Jin, XM Yao, XY Ren, and Q Huang conducted clinical practice guidelines on COVID-19. YH Jin reported research projects involving infection of healthcare workers during this epidemic, which was supported by Special Project for Emergency of Hubei Province (2020FCA008). All other authors declare they have nothing to disclose and have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}